| Time/Date | Headline |
|---|---|
| 30 Apr 2024 | Share Purchases by a PDMR |
| 30 Apr 2024 | Share Purchases by PDMR’s |
| 29 Apr 2024 | Update on AIM Delisting |
| 22 Apr 2024 | TR-1: Notification of major holdings |
| 19 Apr 2024 | Result of GM, Cancellation of Admission to Trading |
| 18 Apr 2024 | Share Purchases by a Director |
| 12 Apr 2024 | Share Purchase by a Director |
| 8 Apr 2024 | TR-1: Notification of major holdings |
| 2 Apr 2024 | Proposed Cancellation of Admission to Trading |
| 14 Mar 2024 | Result of AGM |
AIMX:REDX
Redx Pharma plc Share Price
Redx Pharma is a biotech company in the clinical stage that specializes in finding and creating new, precise, small molecule treatments for cancer and fibrosis.
Recent RNS announcements
Company details
| Industry: | Health Care |
| Sector: | Health Care |
| LEI: | 213800HMS4EBXO589Y37 |
| Region: | Europe |
| Admission date: | 27 Mar 2015 |
| Website: | www.redxpharma.com |
| Twitter: | @RedxPharma |
Instrument details
| ISIN: | GB00BSNB6S51 |
| Exchange: | AIMX |
| Market: | Aim |
| Market Segment: | ASQ1 |
| Market Sector: | AMQ1 |
Results & reports
No results & reports data for this company